|
MGC87042 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.563000E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.61219967668103E-10 |
| Normal-vs-Stage2 |
5.543000E-03 |
| Normal-vs-Stage3 |
6.967500E-04 |
| Normal-vs-Stage4 |
1.713200E-01 |
| Stage1-vs-Stage2 |
3.109200E-01 |
| Stage1-vs-Stage3 |
1.253370E-01 |
| Stage1-vs-Stage4 |
2.585600E-01 |
| Stage2-vs-Stage3 |
7.410400E-01 |
| Stage2-vs-Stage4 |
3.207000E-01 |
| Stage3-vs-Stage4 |
3.487800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.756000E-03 |
| Normal-vs-AfricanAmerican |
1.414290E-04 |
| Normal-vs-Asian |
9.158600E-01 |
| Caucasian-vs-AfricanAmerican |
1.178840E-01 |
| Caucasian-vs-Asian |
8.584000E-03 |
| AfricanAmerican-vs-Asian |
8.823900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.176400E-02 |
| Normal-vs-Female |
3.47960000002256E-06 |
| Male-vs-Female |
5.577000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.639900E-02 |
| Normal-vs-Age(41-60Yrs) |
9.164100E-02 |
| Normal-vs-Age(61-80Yrs) |
1.11339999997462E-07 |
| Normal-vs-Age(81-100Yrs) |
2.639600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.550400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.864200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.285200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.285600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.122600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.033600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.597100E-04 |
| Normal-vs-Grade 2 |
6.97710000885365E-10 |
| Normal-vs-Grade 3 |
5.86499959709386E-10 |
| Normal-vs-Grade 4 |
1.209000E-01 |
| Grade 1-vs-Grade 2 |
8.193000E-01 |
| Grade 1-vs-Grade 3 |
9.288000E-01 |
| Grade 1-vs-Grade 4 |
1.922010E-01 |
| Grade 2-vs-Grade 3 |
3.971200E-01 |
| Grade 2-vs-Grade 4 |
1.837430E-01 |
| Grade 3-vs-Grade 4 |
1.944400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.60110002612424E-09 |
| Normal-vs-ccB subtype |
3.89619999999757E-05 |
| ccA subtype-vs-ccB subtype |
3.314200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.089700E-02 |
| Normal-vs-N1 |
5.889500E-02 |
| N0-vs-N1 |
4.461800E-01 |
|
|
